Astrazeneca Share News (AZN)

AstraZeneca blod clot treatment meets trial endpoint

(Sharecast News) - AstraZeneca on Friday said its Danicopan add-on anti blood-clotting drug had met a primary endpoint in a phase III trial.

AstraZeneca, Sanofi respiratory drug gets EU marketing go-ahead

(Sharecast News) - AstraZeneca and Sanofi said their Beyfortus drug for the prevention of lower respiratory tract disease in newborns and infants has been recommended for marketing authorisation in the European Union

Credit Suisse upgrades GSK, downgrades AstraZeneca

(Sharecast News) - Credit Suisse upgraded GlaxoSmithKline on Thursday but downgraded AstraZeneca as it took a look at the pharmaceuticals sector.

LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday:

UK equities fall despite cooling August inflation

Sept 14 (Reuters) - Britain's main stock indexes fell on Wednesday after a surprise fall in consumer prices did little to calm speculation of a large interest rate hike from the Bank of England next week.

CORRECT: AstraZeneca shares further information on oncology trial data

(Clarifying details of Poseidon trial.)

AstraZeneca beats U.S. shareholder lawsuit over COVID vaccine disclosures

NEW YORK, Sept 12 (Reuters) - AstraZeneca Plc on Monday won the dismissal of a U.S. shareholder lawsuit claiming that it concealed problems in developing its COVID-19 vaccine, making it unlikely the treatment would win regulatory approval in the United States.

AstraZeneca shares further Imfinzi, Tagrisso, Enhertu trial data

(Alliance News) - AstraZenea PLC on Monday shared several positive developments for its oncology pipeline, which will be presented at the European Society for Medical Oncology Congress 2022 in Paris.

AstraZeneca, Merck's Lynparza shows survival benefit in ovarian cancer

(Alliance News) - AstraZeneca PLC and Merck & Co Inc on Friday said their cancer drug lynparza, or olaparib, showed positive overall survival data for patients with ovarian cancer in three phase III studies.

Chasing green goals, corporations push car fleet managers toward EVs

MACCLESFIELD, England, Aug 12 (Reuters) - Large corporations are jumping on the "green" bandwagon left and right, which in turn is pushing firms that lease and manage car fleets to convert to electric vehicles (EVs) faster than they had ever thought possible.

Oxford malaria vaccine data bodes well for effort to combat deadly disease

LONDON, Sept 7 (Reuters) - Encouraging new data on a malaria vaccine from Oxford University bodes well for global effort to combat the mosquito-borne disease that kills a child every minute, its makers said on Wednesday.

UK's FTSE 100 falls as weak oil drags on commodity-linked stocks

Sept 7 (Reuters) - UK's FTSE 100 index fell on Wednesday as weak oil and metal prices pressured commodity-linked stocks, while worries over a possible recession and aggressive monetary tightening in major economies also weighed on sentiment.

LONDON BROKER RATINGS: UBS raises Admiral; Morgan Stanley cuts Astra

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday afternoon:

UK dividends calendar - next 7 days

Sanofi sees EU regulatory decision on its COVID booster in weeks

BRUSSELS, Sept 5 (Reuters) - The European Union's drugs regulator may be a few weeks from deciding whether to approve the experimental COVID-19 vaccine developed by French drugmaker Sanofi and its British partner GSK, a Sanofi executive said on Monday.